Sodium channels contribute to microglia/macrophage activation and function in EAE and MS

Glia
Matthew J CranerStephen G Waxman

Abstract

Loss of axons is a major contributor to nonremitting deficits in the inflammatory demyelinating disease multiple sclerosis (MS). Based on biophysical studies showing that activity of axonal sodium channels can trigger axonal degeneration, recent studies have tested sodium channel-blocking drugs in experimental autoimmune encephalomyelitis (EAE), an animal model of MS, and have demonstrated a protective effect on axons. However, it is possible that, in addition to a direct effect on axons, sodium channel blockers may also interfere with inflammatory mechanisms. We therefore examined the novel hypothesis that sodium channels contribute to activation of microglia and macrophages in EAE and acute MS lesions. In this study, we demonstrate a robust increase of sodium channel Nav1.6 expression in activated microglia and macrophages in EAE and MS. We further demonstrate that treatment with the sodium channel blocker phenytoin ameliorates the inflammatory cell infiltrate in EAE by 75%. Supporting a role for sodium channels in microglial activation, we show that tetrodotoxin, a specific sodium channel blocker, reduces the phagocytic function of activated rat microglia by 40%. To further confirm a role of Nav1.6 in microglial activation, ...Continue Reading

References

Jan 1, 1992·Glia·A R Korotzer, C W Cotman
Aug 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·J D SedgwickV ter Meulen
Feb 1, 1987·Archives of Biochemistry and Biophysics·K V PrasadJ G Kaplan
Mar 1, 1994·Glia·W NörenbergP J Gebicke-Haerter
Aug 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·P K StysS G Waxman
Dec 19, 1995·Proceedings of the National Academy of Sciences of the United States of America·O BagasraH Koprowski
Aug 1, 1996·Trends in Neurosciences·G W Kreutzberg
Mar 1, 1997·Brain : a Journal of Neurology·B FergusonV H Perry
May 5, 1997·The Journal of Cell Biology·M HothR S Lewis
Jan 29, 1998·The New England Journal of Medicine·B D TrappL Bö
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·X WeiM D Cahalan
Dec 14, 1999·The European Journal of Neuroscience·C EderR Nitsch
Mar 2, 2002·Brain : a Journal of Neurology·Marc JacobsenBernhard Hemmer
Jan 31, 2003·Annals of Neurology·Raju KapoorKenneth J Smith
Nov 7, 2003·Glia·Josep SauraJoan Serratosa
Mar 30, 2004·Annals of Neurology·Michael H Barnett, John W Prineas
May 4, 2004·Annals of Neurology·David A BechtoldKenneth J Smith

❮ Previous
Next ❯

Citations

Jan 16, 2007·Journal of Neurology·David A BechtoldKenneth J Smith
Sep 19, 2009·Cell and Tissue Research·Margaret R ByersRuth E Westenbroek
Apr 6, 2013·Neuroscience Bulletin·Li Cao, Cheng He
Aug 21, 2013·CNS Drugs·Amir-Hadi MaghziEmmanuelle Waubant
Jan 30, 2008·Nature Clinical Practice. Neurology·Stephen G Waxman
Jun 10, 2010·The Journal of Biological Chemistry·Andreas GasserSulayman D Dib-Hajj
Dec 31, 2010·The Journal of Biological Chemistry·Doo Yeon KimDora M Kovacs
Jan 13, 2009·The Journal of Biological Chemistry·Michael D CarrithersStephen G Waxman
Jan 30, 2010·Brain : a Journal of Neurology·M IngleseG Johnson
Feb 12, 2010·Brain : a Journal of Neurology·Joel A BlackStephen G Waxman
Sep 11, 2012·Brain : a Journal of Neurology·Niels EijkelkampJohn N Wood
Mar 23, 2013·Brain : a Journal of Neurology·Damineh MorsaliKenneth J Smith
Jul 31, 2007·BMC Neuroscience·Michael A HenryS Rock Levinson
Aug 6, 2010·Biological & Pharmaceutical Bulletin·Gurpreet KaurNirmal Singh
Mar 14, 2012·Marine Drugs·Francisco Rafael NietoCruz Miguel Cendán
Jul 24, 2012·Marine Drugs·Magbubah EssackJohn A C Archer
Feb 5, 2014·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Gyorgy PanyiAntonio Felipe
Nov 30, 2013·Brain : a Journal of Neurology·Sarah Al-IzkiDavid Baker
Mar 19, 2014·Nature Reviews. Neurology·Manuel A FrieseLars Fugger
Nov 30, 2013·Neural Plasticity·Jason R Richardson, Muhammad M Hossain
Oct 3, 2012·Nature Reviews. Neurology·Robin J M FranklinKenneth J Smith
Feb 9, 2016·Autoimmunity Reviews·Anantha Maharasi RamaKrishnan, Kavitha Sankaranarayanan
Oct 9, 2012·Expert Review of Neurotherapeutics·Felix LuessiFrauke Zipp
Sep 2, 2008·Expert Review of Neurotherapeutics·Albert Lo
Jul 4, 2015·International Journal of Molecular Sciences·Andrea Rottlaender, Stefanie Kuerten
Feb 18, 2014·Experimental Neurology·Erik Ellwardt, Frauke Zipp
Apr 9, 2015·NMR in Biomedicine·Maria PetraccaMatilde Inglese
May 31, 2011·Best Practice & Research. Clinical Anaesthesiology·Eva Zindler, Frauke Zipp
Feb 4, 2010·Pharmacology & Therapeutics·Anneke Van der WaltTrevor Kilpatrick

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.